Sean Bohen Olema Pharmaceuticals, Inc. (OLMA) insider trading activity

Sean Bohen is President and CEO of Olema Pharmaceuticals, Inc.. Currently has a direct ownership of 237,650 shares of OLMA, which is worth approximately $2.07 Million. The most recent transaction as insider was on Dec 26, 2025, when has been sold 8,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 238K

1.66% 3M change

1.66% 12M change

Total Value Held $2.07 Million

Sean Bohen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 26 2025	SELL Bona fide gift	-	8,500 Reduced 3.45%	237,650 Common Stock
Dec 11 2024	SELL Open market or private sale	$516,281 $9.03 p/Share	57,174 Reduced 19.13%	241,662 Common Stock
Dec 10 2024	SELL Open market or private sale	$490,313 $9.37 p/Share	52,328 Reduced 14.9%	298,836 Common Stock
Dec 09 2024	BUY Grant, award, or other acquisition	-	204,750 Added 36.83%	351,164 Common Stock
Nov 22 2023	SELL Open market or private sale	$388,254 $13.9 p/Share	27,932 Reduced 16.16%	144,925 Common Stock
Nov 21 2023	SELL Open market or private sale	$441,445 $15.07 p/Share	29,293 Reduced 14.49%	172,857 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	110,250 Added 35.29%	202,150 Common Stock

Sep 21 2022	BUY Grant, award, or other acquisition	-	20,000 Added 21.21%	74,279 Common Stock
Oct 14 2021	SELL Open market or private sale	$154,000 $30.8 p/Share	5,000 Reduced 8.69%	52,514 Common Stock
Oct 14 2021	BUY Exercise of conversion of derivative security	$24,100 $4.82 p/Share	5,000 Added 8.0%	57,514 Common Stock
Sep 27 2021	SELL Open market or private sale	$32,626 $30.07 p/Share	1,085 Reduced 2.02%	52,514 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$5,230 $4.82 p/Share	1,085 Added 1.98%	53,599 Common Stock
Sep 08 2021	SELL Open market or private sale	$78,930 $30.0 p/Share	2,631 Reduced 4.77%	52,514 Common Stock
Sep 08 2021	BUY Exercise of conversion of derivative security	$12,681 $4.82 p/Share	2,631 Added 4.42%	56,905 Common Stock
Sep 07 2021	SELL Open market or private sale	$12,423 $30.08 p/Share	413 Reduced 0.76%	54,274 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$1,991 $4.82 p/Share	413 Added 0.75%	54,687 Common Stock
Sep 01 2021	SELL Open market or private sale	$26,174 $30.05 p/Share	871 Reduced 1.58%	54,274 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$4,198 $4.82 p/Share	871 Added 1.55%	55,145 Common Stock
Sep 23 2020	BUY Exercise of conversion of derivative security	$248,948 $4.82 p/Share	51,649 Added 50.0%	51,649 Common Stock

Sean Bohen

President and CEO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OLMA shares.

Notify only if

Value

Insider Trading

Get notified when an Olema Pharmaceuticals, Inc. insider buys or sells OLMA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Olema Pharmaceuticals, Inc.

Track Activities on OLMA

Account